Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

7 results about "Pyruvate oxidase" patented technology

In enzymology, a pyruvate oxidase (EC 1.2.3.3) is an enzyme that catalyzes the chemical reaction pyruvate + phosphate + O₂ ⇌ acetyl phosphate + CO₂ + H₂O₂ The 3 substrates of this enzyme are pyruvate, phosphate, and O₂, whereas its 3 products are acetyl phosphate, CO₂, and H₂O₂. This enzyme belongs to the family of oxidoreductases, specifically those acting on the aldehyde or oxo group of donor with oxygen as acceptor.

Genetically engineered bacterium for synthesizing N-acetyl blue as well as construction method and application of genetically engineered bacterium

PendingCN122038258ABacteriaMicroorganism based processesAconitaseEnzyme inhibition
The invention discloses a genetically engineered bacterium for synthesizing N-acetyl blue as well as a construction method and application of the genetically engineered bacterium. The genetically engineered bacterium is prepared by knocking out a lactic dehydrogenase gene ldh and inserting a phosphoketolase gene xfpK on a knockout site, knocking out a pyruvate oxidase gene poxB and inserting a phosphate transacetylase gene pta on a knockout site of a microorganism for producing N-acetyl blue, and knocking out an aconitase inhibition factor gene acnR, inserting a glutamate dehydrogenase gene gdhA on a knockout site, knocking out a glutamine synthetase adenylation transferase gene glnE, and inserting an alpha-ketoglutarate dehydrogenase inhibition factor gene odhI on a knockout site to obtain the strain. According to the method, the supply of the precursor acetyl coenzyme A is enhanced by introducing a non-oxidative glycolysis pathway, the pH dynamic regulation system balances the metabolic flux, and the double breakthrough of the yield and the carbon recovery rate of the N-acetyl blue is realized by combining a two-stage fermentation process.
Owner:VERTEXYN (NANJING) BIOWORKS CO LTD

A periodontitis-targeted antibacterial supramolecular material, its preparation method and application

ActiveCN121401416BHigh enrichment ratereduce exposureAntibacterial agentsPeptide/protein ingredientsPeriodontal pathogenPtru catalyst
This invention discloses a periodontitis-targeted antibacterial supramolecular material, its preparation method, and its application. It belongs to the field of catalyst technology. The preparation method of the periodontitis-targeted antibacterial supramolecular material includes the following steps: dissolving 2,5-dihydroxyterephthalic acid and tetrakis(4-aminophenyl)porphyrin in a first solvent, adding a first catalyst to react, and obtaining a DHA-TAPP COF skeleton; dispersing the DHA-TAPP COF skeleton in a second solvent, adding 3-bromopropyltrimethylammonium bromide and a second catalyst to react, and obtaining Q-COF; dispersing Q-COF in a third solvent, mixing it with H2PtCl6 solution, and then placing it under light conditions to obtain Pt-Q-COF; dispersing Pt-Q-COF in a buffer solution, adding pyruvate oxidase for adsorption treatment, and obtaining POx-Pt-Q-COF. This invention achieves a synergistic effect of "targeted enrichment - dual ROS generation - closed-loop H2O2 supply" through material structure design and functional unit integration, thereby improving the clearance efficiency of periodontal pathogens while ensuring biocompatibility.
Owner:JILIN UNIVERSITY

Periodontitis targeted antibacterial supramolecular material as well as preparation method and application thereof

The invention discloses a periodontitis-targeted antibacterial supramolecular material and a preparation method and application thereof, and belongs to the technical field of catalysts.The preparation method of the periodontitis-targeted antibacterial supramolecular material comprises the following steps that 2, 5-dihydroxy terephthalic acid and tetra (4-aminophenyl) porphyrin are dissolved in a first solvent, stirring is carried out, and a mixture is obtained; a first catalyst is added for a reaction, and a DHA-TAPP COF skeleton is obtained; the DHA-TAPP COF skeleton is dispersed in a second solvent, 3-bromopropyl trimethyl ammonium bromide and a second catalyst are added for a reaction, and Q-COF is obtained; the Q-COF is dispersed in a third solvent and mixed with an H2PtCl6 solution, then the mixture is placed under the illumination condition, and Pt-Q-COF is obtained; the Pt-Q-COF is dispersed in a buffer solution, pyruvate oxidase is added for adsorption treatment, and the POx-Pt-Q-COF is obtained. Through material structure design and functional unit integration, the synergistic effect of targeting enrichment, double ROS generation and closed-loop H2O2 supply is achieved, the periodontal pathogenic bacterium removal efficiency is improved, and meanwhile the biocompatibility is guaranteed.
Owner:JILIN UNIVERSITY

Construction of a recombinant escherichia coli and its use in the synthesis of heme derivatives

The present application provides a recombinant E. coli for synthesizing heme and derivatives thereof, wherein the recombinant E. coli is knocked out of genes such as pyruvate oxidase poxB, pyruvate formate-lyase pflB and protoporphyrinogen peroxidase yfeX, and meanwhile, the genes such as phosphopyruvate carboxylase ppc, glycerol transporter glpF and 3-phosphoglycerate dehydrogenase glpD are enhanced, and the genes such as 5-aminovaleryl-CoA synthase hemA and ferrous chelatase hemH are introduced, so that the recombinant E. coli can synthesize heme and derivatives thereof by using glycerol as a raw material, and has application prospects in the field of biological manufacturing.
Owner:WEIYUAN SYNTHETIC BIOTECHNOLOGY (QINHUANGDAO) CO LTD

Construction method and application of escherichia coli capable of producing fumaric acid

The invention discloses a construction method and application of escherichia coli capable of producing fumaric acid, and belongs to the technical field of biological engineering. By-product synthesis related genes such as a fumarase coding gene fumA, a lactic dehydrogenase coding gene ldhA and a pyruvate oxidase coding gene poxB are knocked out, so that the yield of fumaric acid is effectively increased, and the content of heteroacid is reduced. On the basis, the expression of Afpyc, Ecppc and EcaceA genes is up-regulated independently or in a combined manner. The genetically engineered bacterium constructed by the invention adopts an aerobic-microaerobic two-stage fermentation strategy in a 5L fermentation tank, the highest yield of fumaric acid reaches 50.2 g / L after fermentation for 60 hours, the glucose conversion rate is 0.48 g / g, and the by-products lactic acid and acetic acid are both controlled to be 4-5g / L. The strain does not need to carry plasmids, so that the risks of antibiotic use and plasmid loss are avoided, and the strain has good industrial application potential.
Owner:JIANGNAN UNIV

Blood ammonia determination kit

PendingCN121344148AMicrobiological testing/measurementGlutamine synthasePeroxidase
The invention discloses a blood ammonia determination kit. The kit comprises a reagent 1 (R1) and a reagent 2 (R2), the kit is characterized in that the reagent 1 consists of the following components: a buffer solution, inorganic salt, glutamic acid, ATP, TOOS, peroxidase, glutamine synthetase, pyruvate oxidase, pyruvic acid and a preservative; the reagent 2 is prepared from the following components: a buffer solution, a surfactant, MBTH, a deoxidant, BSA and a preservative. The kit disclosed by the invention takes Trinder reaction as a basic principle, develops color in an MBTH + chromogen mode, successfully solves the problem of poor airborne stability by adding a deoxidant and stabilizing MBTH by specific surface activity, and is relatively good in overall performance evaluation result of the reagent.
Owner:BEIJING LEADMAN BIOCHEM